Cellular reprogramming is the hottest topic in longevity science, with tech titans like Sam Altman investing in it. It's now ...

A team has identified an experimental molecule capable of "reprogramming" the brain's immune cells to restore part of their ...

NewLimit Series C raises $435M led by Founders Fund as Armstrong-backed startup moves epigenetic therapies toward human ...

NewLimit Raises $435M to advance longevity medicine trials, expand ageing research programmes and accelerate clinical growth.

Retinal degeneration leads to irreversible vision loss and significantly impacts quality of life. Approximately 19.83 million Americans over the age of 40 are affected by age-related macular ...

※ Affiliations and titles are as of the end of the research activity. This research area comprises several fields (including cellular reprogramming, transdifferentiation and stem cell biology) in ...

For years, Silicon Valley treated ageing as a background fact of life rather than a technical problem. Wealth from the AI boom is now flowing into laboratories studying cells, proteins, and human ...

A University of Toronto study reveals that neural crest stem cells, found in the skin and other areas, are responsible for the generation of reprogrammed neurons, contradicting the prevailing theory ...

A recent online debate has ignited regarding AI's impact on healthcare and human ageing, following a viral post about Sam Altman's massive investment in longevity startup Retro Biosciences.

※ Affiliations and titles are as of the end of the research activity. This research area includes research to elucidate epigenetic control and biological functions. More specifically, this includes ...